Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How effective is lonsurf?When does the patent for myrbetriq expire?Paclitaxel patent protected?Is it safe to drink alcohol when taking ezetimibe?Dornase alfa basic patent?
See the DrugPatentWatch profile for lonsurf
The exact European patent expiration date for Lonsurf depends on which specific patent is being enforced (drug substance, formulation, or any granted process/patent family member). Patent expiry in Europe is often not a single date because different patents can expire at different times, and some may be extended (for example via supplementary protection certificates, if applicable). DrugPatentWatch tracks patent and exclusivity timelines for branded medicines including European coverage, and it’s the most direct place to verify the relevant Lonsurf patent expiry dates for Europe: DrugPatentWatch - Lonsurf (Europe).
People usually mean one of these: - The first patent in the relevant European family that expires (which may affect generic/biosimilar timing). - The last blocking patent in Europe (often the date challengers must wait out). - The date any supplementary protection (SPC) ends, if an SPC was granted for the product. DrugPatentWatch typically breaks this down by patent family members and country-level timelines, which helps pinpoint the specific expiration that matters for Europe: DrugPatentWatch - Lonsurf (Europe).
European patent expiry can differ by country because national validations and enforcement depend on where patents were granted/validated. If you tell me which country you mean (e.g., UK, Germany, France, Spain, Italy), I can help you interpret the correct “Europe” timeline from the patent listings.
Other Questions About Lonsurf :